ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.60363
-0.03%
Brent Oil
83.905
0.17%
Bitcoin
66,331.66
-0.91%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Accelerated Pharma (MM) (ACCP)

  7. Accelerated Pharma (MM) (ACCP) Noticias

ACCP

ACCELERATED PHARMA, INC. (ACCP)

Accelerated Pharma (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ACCP
FechaHoraFuenteTítuloSímboloCompañía
22/04/202011:45Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACCPAccelerated Pharma (MM)
06/02/202008:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACCPAccelerated Pharma (MM)
05/02/202010:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACCPAccelerated Pharma (MM)
08/11/201905:00Edgar (US Regulatory)Effectiveness Order (effect)NASDAQ:ACCPAccelerated Pharma (MM)
06/11/201905:06Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
22/10/201805:06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ACCPAccelerated Pharma (MM)
23/08/201711:10Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ACCPAccelerated Pharma (MM)
18/04/201713:22Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ACCPAccelerated Pharma (MM)
04/02/201008:00PR Newswire (US)Access Pharmaceuticals Initiates Program Applying Cobalamin Platform to siRNA Drug DeliveryNASDAQ:ACCP
02/02/201014:22PR Newswire (US)Access Pharmaceuticals Announces Closing of $6.3 Million in Registered Direct OfferingNASDAQ:ACCP
22/01/201008:29PR Newswire (US)Access Pharmaceuticals Raises $6.3 Million In Registered Direct OfferingNASDAQ:ACCP
19/01/201008:00PR Newswire (US)Access Pharmaceutical's Cobalamin Oral Insulin Achieves Greater Than 80% Oral Bioavailability In Preclinical ModelsNASDAQ:ACCP
07/01/201007:30PR Newswire (US)Access Pharmaceuticals Announces Completion of ProLindac Monotherapy Trial and Initiation of Combination StudyNASDAQ:ACCP
06/01/201008:00PR Newswire (US)Access Pharmaceuticals To Present at OneMedPlace Forum 2010NASDAQ:ACCP
15/12/200908:00PR Newswire (US)Access Pharmaceuticals Appoints Sales and Marketing ExecutiveNASDAQ:ACCP
03/12/200911:48PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in EuropeNASDAQ:ACCP
17/11/200908:00PR Newswire (US)ChangeWave Issues Buy Recommendation on Access PharmaceuticalsNASDAQ:ACCP
11/11/200908:00PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North AmericaNASDAQ:ACCP
15/10/200907:00PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians FeedbackNASDAQ:ACCP
06/10/200907:00PR Newswire (US)Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)NASDAQ:ACCP
11/09/200908:00PR Newswire (US)Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United StatesNASDAQ:ACCP
10/09/200908:00PR Newswire (US)Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development PlanNASDAQ:ACCP
01/09/200908:00PR Newswire (US)Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare ConferenceNASDAQ:ACCP
03/08/200905:00PR Newswire (US)Access Pharmaceuticals Provides Update on ProLindac Clinical Development ProgramNASDAQ:ACCP
29/07/200908:00PR Newswire (US)Access Pharmaceuticals Announces New MuGard Commercial Strategy in North AmericaNASDAQ:ACCP
27/07/200908:00PR Newswire (US)Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharmNASDAQ:ACCP
23/07/200908:00PR Newswire (US)MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer PatientsNASDAQ:ACCP
22/07/200910:08PR Newswire (US)UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock ConferenceNASDAQ:ACCP
22/07/200908:00PR Newswire (US)Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock ConferenceNASDAQ:ACCP
13/07/200907:30PR Newswire (US)Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales ConfeNASDAQ:ACCP
 Showing the most relevant articles for your search:NASDAQ:ACCP

Su Consulta Reciente

USOTC
FSDK
First Citizens National ... (CE)
ASX
MGF
Magellan Global
TG
ICLA
Cell Impact
LSE
BP65
Sw.fin.43
ASX
YTMMQ1
Equity Trustees
NASDAQ
ACABW
Atlantic Coastal Acquisi...
BIT
P1QT76
BNP Paribas Issuance
TG
SSG0
SPDR Oil & Gas Equipment...
BOV
PETRF322
PETRF322 Ex:28,2
BOV
K1SS34R
Kohl`s
BIT
P1SHL5
BNP Paribas Issuance
DGFX
OPTCMUSDT
Optimus
BIT
P1FCV2
BNP Paribas Issuance
ASX
TKGCB
LSE
SY01
Stan.ch.bk.24
EU
HEIJM
Royal Heijmans NV
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados